English  |  正體中文  |  简体中文  |  Items with full text/Total items : 6024/14565 (41%)
Visitors : 14097477      Online Users : 151
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.fy.edu.tw:8080/ir/handle/987654321/14450

    Title: Cisplatin Disrupts the Latency of Human Herpesvirus 8 and Induces Apoptosis in Primary Effusion Lymphoma Cells.
    Authors: Yi-Fen Wang;Yee-Hsuan Chiou;Lin-Yu Wang;Su-Ting Chang;Huey-Wen Shyu;Chang-Yu Chen;Kuan-Hua Lin;Miao-Chen Chou
    Contributors: 輔英科技大學 醫學檢驗生物技術系
    Keywords: Cisplatin, Primary effusion lymphoma, LANA, vFLIP, p53
    Date: 2012-05-01
    Issue Date: 2012-09-03 16:30:11 (UTC+8)
    Abstract: Human herpesvirus 8 (HHV8) is the etiologic agent for primary effusion lymphoma (PEL). The aim of this study is to investigate the effects of cisplatin on the PEL cells. Cisplatin treatment induced apoptosis and inhibited the growth of PEL cells, and the effect was more profound in the HHV8-positive lymphoma cells compared with the EBV-positive lymphoma cells. Cisplatin treatment decreased the expression of HHV8 latent genes and activated p53 at serine 15 in PEL cells. Our results indicate that cisplatin can disrupt HHV8 latency and induce reactivation of p53 and highly selective treatment modality for this virally induced lymphoma.
    Relation: Cancer Investigation 30(4),268-274
    Appears in Collections:[醫學檢驗生物技術系] 期刊論文

    Files in This Item:

    There are no files associated with this item.

    All items in FYIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback